We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Blood Test Predicts Diabetes Risk in Early Pregnancy

By LabMedica International staff writers
Posted on 13 Jun 2013
Levels of a biomarker in a pregnant woman's blood can help physicians gauge her risk of developing gestational diabetes during the first trimester. More...


Gestational diabetes causes glucose levels in the bloodstream to be higher than normal and early diagnosis and treatment can help the woman manage the condition, because if left untreated there is an increased the risk of premature delivery.

Endocrinologists at Tokyo Women's Medical University (Japan) conducted a prospective cohort study of 716 pregnant women who first visited the hospital during their first trimester between 2010 and 2011. Plasma samples were obtained at the time of routine blood testing during the first trimester, at less than 14 weeks gestation. Blood glucose levels were determined.

Enzyme-linked immunosorbent assays (ELISA) were performed in duplicate to determine the levels of soluble (pro)renin receptor [s(P)RR] using commercially available kits (Immuno-Biological Laboratories Co.; Fujioka, Japan). The detection limit of the kit was 24 pg/mL, and inter- and intra-assay coefficients of variation were 7.5% and 5.5%, respectively.

Among the 716 participants, there were 44 (6.1%) women who had gestational diabetes mellitus (GDM) and 672 (93.9%) who did not. The team found that pregnant women with elevated s(P)RR levels were more likely to be diagnosed with gestational diabetes. Women who had the highest s(P)RR levels of above 34.2 ng/mL were 2.9 times more likely to develop gestational diabetes than women who had the lowest levels. All s(P)RR concentrations were above the level required for detection of 24 pg/mL and the mean s(P)RR of the entire cohort was 30.6 ± 9.5 ng/mL.

Atsuhiro Ichihara, MD, a senior author of the study said, “In addition to gestational diabetes, recent studies have found elevated s(P)RR levels are associated with the birth of larger babies and high blood pressure in late pregnancy. The evidence suggests the biomarker is important in the interaction between mother and fetus during pregnancy." The study was published on May 29, 2013, in the Journal of Clinical Endocrinology & Metabolism.

Related Links:
Tokyo Women's Medical University

Immuno-Biological Laboratories





Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
POC Immunoassay Analyzer
Procise DX
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.